Comaingking, Rea Mea B.
HRN: 23-13-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2023
CO-AMOXICLAV 625MG (TAB)
06/10/2023
06/17/2023
PO
625 Mg
Every 12 Hours
S/P Episiorrhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes